Dr. Chatta is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Elm and Carlton St
Buffalo, NY 14263Phone+1 716-845-2300Fax+1 716-845-3519
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 1995 - 1996- University of WashingtonFellowship, Geriatric Medicine (Internal Medicine), 1988 - 1992
Aurora Health CareResidency, Internal Medicine, 1986 - 1988
SSM Health/Saint Louis University School of MedicineResidency, Pediatrics, 1985 - 1985
Delhi University College of Medical SciencesClass of 1979
Certifications & Licensure
NY State Medical License 2016 - 2025
WA State Medical License 1988 - 2025
AK State Medical License 2015 - 2024
PA State Medical License 2001 - 2024
AR State Medical License 1997 - 2001
WI State Medical License 1986 - 1989- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Decitabine/Cedazuridine and Enzalutamide for the Treatment of Metastatic Castrate Resistant Prostate Cancer Start of enrollment: 2022 Jan 26
Roles: Principal Investigator, Contact
- Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery Start of enrollment: 2019 Nov 29
Roles: Contact, Principal Investigator
- Nutrition and Exercise Interventions in Reducing Androgen Deprivation Therapy-Induced Obese Frailty in Prostate Cancer Survivors Start of enrollment: 2019 May 02
Roles: Contact, Principal Investigator
- Join now to see all
Publications & Presentations
PubMed
- A phase II open label, randomized clinical trial of atezolizumab with or without human recombinant IL-7 (CYT107) in advanced urothelial cancer.Randy F Sweis, Gurkamal S Chatta, Rohit K Jain, Helen Moon, Scott Edward Delacroix
Clinical Cancer Research. 2024-11-22 - 3 citationsAdjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma.Andrea B Apolo, Karla V Ballman, Guru Sonpavde, Stephanie Berg, William Y Kim
The New England Journal of Medicine. 2024-09-15 - 1 citationsIntegrated single-cell analysis defines the epigenetic basis of castration-resistant prostate luminal cells.Jason S Kirk, Jie Wang, Mark Long, Spencer Rosario, Amanda Tracz
Cell Stem Cell. 2024-08-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
